Closing Bell: Briacell Therapeutics Corp up on Tuesday (BCT)

Today, shares of Briacell Therapeutics Corp opened at $1.31 and closed at $1.30. Intraday prices ranged from a low of $1.24 to a high of $1.33.

Shares raised 4.00 percent from the previous day's close of $1.25.

During the day across North America, the TSX Composite closed 0.34% at 22751.68, the S&P 500 closed 0.28% at 5631.22, the Dow Jones Industrial Average closed 0.53% at 40211.72 and the Nasdaq Composite closed 0.40% at 18472.57.

Briacell Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker BCT.

Trading volume was 6,800 on 56 total trades. On average, Briacell Therapeutics Corp has traded 5,178 shares over 5 days and 8,288 year-to-date.

The TSX overall saw 4,226 price advancers against 1,023 declines and 82 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $1.18 (July 12,2024). Moreover, the shares have plummeted -84.69 percent in the last 12 months, while they have shrunken -83.33% this year.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $22.86 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Briacell Therapeutics Corp's consensus rating is "Strong Buy" based on 1 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..